Levomefolate calcium 0.451 MG Oral Tablet — RxCUI 1013628
RxNorm drug concept · Semantic clinical drug
RxCUI 1013628
Semantic clinical drug · SCD
● Current RxNorm concept 6 FDA products
12 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1013628
Official nameLevomefolate calcium 0.451 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped6
Package NDCs mapped12
Reported Medicaid activity (SDUD)10,895 prescriptions · 33 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
🕸️ Concept Web — How Levomefolate calcium 0.451 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Levomefolate calcium 0.451 MG Oral Tablet
RxCUI 1013628 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Levomefolate
1592257IN -
Levomefolate calcium
1028454PIN
-
Levomefolate
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Levomefolate Oral Tablet
1013627SCDF -
Levomefolate calcium Oral Tablet
2648456SCDFP -
Levomefolate Oral Product
1861728SCDG -
Levomefolate Pill
1861729SCDG -
Levomefolate calcium Oral Product
2661439SCDGP -
Levomefolate calcium Pill
2663593SCDGP -
Oral Tablet
317541DF -
Oral Product
1151131DFG - +1 more in this family
-
Levomefolate Oral Tablet
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Levomefolate calcium 0.451 MG
1013623SCDC
-
Levomefolate calcium 0.451 MG
-
Packs 6
Fixed collections of drugs packaged and sold together, like dose packs.
-
{21 (drospirenone 3 MG / ethinyl estradiol 0.03 MG / levomefolate calcium 0.451 MG Oral Tablet) / 7 (levomefolate calcium 0.451 MG Oral Tablet) } Pack [Safyral 28 Day]
1050494BPCK -
{21 (drospirenone 3 MG / ethinyl estradiol 0.03 MG / levomefolate calcium 0.451 MG Oral Tablet) / 7 (levomefolate calcium 0.451 MG Oral Tablet) } Pack [Tydemy 28 Day]
1999724BPCK -
{24 (drospirenone 3 MG / ethinyl estradiol 0.02 MG / levomefolate calcium 0.451 MG Oral Tablet) / 4 (levomefolate calcium 0.451 MG Oral Tablet) } Pack [Beyaz 28 Day]
1013630BPCK -
{24 (drospirenone 3 MG / ethinyl estradiol 0.02 MG / levomefolate calcium 0.451 MG Oral Tablet) / 4 (levomefolate calcium 0.451 MG Oral Tablet) } Pack [Rajani 28 Day]
1813112BPCK -
{21 (drospirenone 3 MG / ethinyl estradiol 0.03 MG / levomefolate calcium 0.451 MG Oral Tablet) / 7 (levomefolate calcium 0.451 MG Oral Tablet) } Pack
1050493GPCK -
{24 (drospirenone 3 MG / ethinyl estradiol 0.02 MG / levomefolate calcium 0.451 MG Oral Tablet) / 4 (levomefolate calcium 0.451 MG Oral Tablet) } Pack
1013629GPCK
-
{21 (drospirenone 3 MG / ethinyl estradiol 0.03 MG / levomefolate calcium 0.451 MG Oral Tablet) / 7 (levomefolate calcium 0.451 MG Oral Tablet) } Pack [Safyral 28 Day]
Showing up to 8 concepts per family — 17 of 18 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
{21 (drospirenone 3 MG / ethinyl estradiol 0.03 MG / levomefolate calcium 0.451 MG Oral Tablet) / 7 (levomefolate calcium 0.451 MG Oral Tablet) } Pack
GPCK · 1050493 -
{24 (drospirenone 3 MG / ethinyl estradiol 0.02 MG / levomefolate calcium 0.451 MG Oral Tablet) / 4 (levomefolate calcium 0.451 MG Oral Tablet) } Pack
GPCK · 1013629 -
Levomefolate calcium 0.451 MG
SCDC · 1013623 -
Levomefolate Oral Tablet
SCDF · 1013627 -
Levomefolate calcium Oral Tablet
SCDFP · 2648456 -
Levomefolate Oral Product
SCDG · 1861728 -
Levomefolate Pill
SCDG · 1861729 -
Levomefolate calcium Oral Product
SCDGP · 2661439 -
Levomefolate calcium Pill
SCDGP · 2663593
Brand-Name Concepts
-
{21 (drospirenone 3 MG / ethinyl estradiol 0.03 MG / levomefolate calcium 0.451 MG Oral Tablet) / 7 (levomefolate calcium 0.451 MG Oral Tablet) } Pack [Safyral 28 Day]
BPCK · 1050494 -
{21 (drospirenone 3 MG / ethinyl estradiol 0.03 MG / levomefolate calcium 0.451 MG Oral Tablet) / 7 (levomefolate calcium 0.451 MG Oral Tablet) } Pack [Tydemy 28 Day]
BPCK · 1999724 -
{24 (drospirenone 3 MG / ethinyl estradiol 0.02 MG / levomefolate calcium 0.451 MG Oral Tablet) / 4 (levomefolate calcium 0.451 MG Oral Tablet) } Pack [Beyaz 28 Day]
BPCK · 1013630 -
{24 (drospirenone 3 MG / ethinyl estradiol 0.02 MG / levomefolate calcium 0.451 MG Oral Tablet) / 4 (levomefolate calcium 0.451 MG Oral Tablet) } Pack [Rajani 28 Day]
BPCK · 1813112
📦 FDA Products & Package NDCs
6 products · 12 package NDCs
12 package NDCs map to RxCUI 1013628 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00781-4075-15 | 3 BLISTER PACK in 1 CARTON (0781-4075-15) / 1 KIT in 1 BLIS... | Drospirenone/Ethinyl Estradiol/Levomefolate Calcium and Levomefolate Calcium | Sandoz Inc | 2016-10-12 |
| 00781-4103-15 | 3 BLISTER PACK in 1 PACKAGE (0781-4103-15) / 1 KIT in 1 BLI... | Drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium | Sandoz Inc | 2015-08-01 |
| 50419-0403-00 | 90 BLISTER PACK in 1 PACKAGE (50419-403-00) / 1 KIT in 1 BL... | Safyral | Bayer HealthCare Pharmaceuticals Inc. | 2012-02-13 |
| 50419-0403-03 | 3 BLISTER PACK in 1 PACKAGE (50419-403-03) / 1 KIT in 1 BLI... | Safyral | Bayer HealthCare Pharmaceuticals Inc. | 2012-02-13 |
| 50419-0403-70 | 90 BLISTER PACK in 1 PACKAGE (50419-403-70) / 1 KIT in 1 BL... | Safyral | Bayer HealthCare Pharmaceuticals Inc. | 2012-02-13 |
| 50419-0403-75 | 12 PACKAGE in 1 CARTON (50419-403-75) / 5 BLISTER PACK in 1... | Safyral | Bayer HealthCare Pharmaceuticals Inc. | 2012-02-13 |
| 50419-0407-00 | 90 BLISTER PACK in 1 PACKAGE (50419-407-00) / 1 KIT in 1 BL... | Beyaz | Bayer HealthCare Pharmaceuticals Inc. | 2010-10-07 |
| 50419-0407-03 | 3 BLISTER PACK in 1 PACKAGE (50419-407-03) / 1 KIT in 1 BLI... | Beyaz | Bayer HealthCare Pharmaceuticals Inc. | 2010-10-07 |
| 50419-0407-70 | 90 BLISTER PACK in 1 PACKAGE (50419-407-70) / 1 KIT in 1 BL... | Beyaz | Bayer HealthCare Pharmaceuticals Inc. | 2010-10-07 |
| 50419-0407-75 | 12 PACKAGE in 1 CARTON (50419-407-75) / 5 BLISTER PACK in 1... | Beyaz | Bayer HealthCare Pharmaceuticals Inc. | 2010-10-07 |
| 68180-0894-73 | 3 POUCH in 1 CARTON (68180-894-73) / 1 BLISTER PACK in 1 PO... | drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium | Lupin Pharmaceuticals, Inc. | 2018-08-22 |
| 68180-0904-73 | 3 POUCH in 1 CARTON (68180-904-73) / 1 BLISTER PACK in 1 PO... | Tydemy | Lupin Pharmaceuticals, Inc. | 2020-11-20 |
Observed labelers:
Bayer HealthCare Pharmaceuticals Inc. (8) ·
Lupin Pharmaceuticals, Inc. (2) ·
Sandoz Inc (2)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.